NFG vs REGN · P/E 10, rev $2.28B vs P/E 14, rev $14.34B
National Fuel Gas Company (NFG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
National Fuel Gas Company (NFG) is a oil & gas integrated company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported NFG revenue for 2025-09-30 was $2.28B. Net income was $518.5M. Revenue was up 17.1% from 2024-09-30 to 2025-09-30. NFG currently screens at market cap $7.22B and trailing P/E 10.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
NFG currently screens at market cap $7.22B and trailing P/E 10.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the NFG and REGN stock pages for the full models.
Not investment advice.